Chronic Kidney Disease after Acute Kidney Injury: A Systematic Review and Meta-analysis
By S. Coca, Swathi Singanamala, C. Parikh. Kidney International, 2011
2,046 citations recorded by the source corpus.
Acute kidney injury may increase the risk for chronic kidney disease and end-stage renal disease. In an attempt to summarize the literature and provide more compelling evidence, we conducted a systematic review comparing the risk of CKD, ESRD and death in patients with and without AKI. From electronic databases, web search engines, and bibliographies, 13 cohort studies were selected, evaluating long-term renal outcomes and non-renal outcomes in patients with AKI. The pooled incidence of CKD and ESRD were 25.8/100 person-years and 8.6 per 100 person-years, respectively. Patients with AKI had higher risks of developing CKD (pooled adjusted hazard ratio 8.8, 95% CI 3.1-25.5), ESRD (pooled adjusted HR 3.1, 95% CI 1.9-5.0) and mortality (pooled adjusted HR 2.0, 95% CI 1.3-3.1) than patients without AKI. The relationship between AKI and CKD or ESRD was graded depending on the severity of AKI and the effect size was dampened by decreased baseline glomerular filtration rate. Data were limited, but AKI was also independently associated with the risk for cardiovascular disease and congestive heart failure, but not with hospitalization for stroke or all-cause hospitalizations. Meta-regression did not identify any study level factors that were associated with the risk for CKD or ESRD. Our review identifies AKI as an independent risk factor for CKD, ESRD, and death and other important non-renal outcomes.
Subfields: Nephrology
View Paper: https://www.semanticscholar.org/paper/8f72f1d602c855426e6799c1c04f9581ccca9c06
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Nephrology
- A. Levey
- Josef Coresh
- Marcello Tonelli
- Harold I. Feldman
- A. Levin
- R. Gansevoort
- Giuseppe Remuzzi
- R. Mehta
Citations in the corpus
- World incidence of AKI: a meta-analysis. (2013, neutral): “6 per 100 personyears, respectively (24).”
- AKI in Hospitalized Patients with COVID-19. (2020, neutral): “002 White 954 (24) 439 (24) 515 (24) Black 1054 (36) 536 (29) 518 (24) Hispanic 1038 (26) 439 (24) 599 (28) Asian 173 (4) 74 (4) 99 (5) Other or unknown 774 (19) 347 (19) 427 (20) Comorbidities, n (%) Hypertension 1527 (38) 820 (45) 707 (33) ,0.”
- Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. (2017, background): “In a recent meta-analysis, survivors of hospital-associated AKI had an 8-fold increased risk of developing CKD.(84) AKI is common in all populations irrespective of geographical location: while aetiologies may vary, the impact of episodes of AKI due to ischemia, toxins, inflammation, or some combina”
- Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance (2021, background): “Moreover, incomplete recovery from AKI can trigger renal fibrosis and thus increase the risk of chronic kidney disease (CKD) and end-stage renal failure (ESRD) [6-8].”